Stress-Related Blood Pressure Surges and Labile Hypertension: A Neurocardiovascular Phenotype Across the Continuum of Cardiovascular Risk
Preprint
- 24 June 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Transient stress-related blood pressure elevations are common in clinical practice, particularly among individuals with anxiety traits, autonomic hyperreactivity, or adverse psychosocial exposure, yet their prognostic significance and management remain unclear. While blood pressure variability is increasingly recognised as an independent cardiovascular risk factor, episodic hypertensive peaks are often considered benign when baseline office or ambulatory blood pressure values are normal. However, recurrent blood pressure surges may contribute to cumulative vascular and organ damage through repeated pulsatile stress, endothelial dysfunction, and transient increases in left ventricular afterload, whereas unnecessary antihypertensive therapy may induce hypotension during inter-episode periods.Psychological stress, anxiety disorders, trauma-related syndromes, and autonomic dysregulation can trigger transient blood pressure elevations via sympathetic activation, hypothalamic-pituitary-adrenal axis stimulation, central renin-angiotensin signalling, and impaired baroreflex control. Repeated neurohormonal activation may progressively impair vascular function and facilitate the transition from reactive blood pressure elevations to sustained hypertension. Increased blood pressure variability has been associated with target organ damage, cardiovascular events, stroke, renal dysfunction, and mortality independently of mean blood pressure levels. Similarly, exaggerated blood pressure responses to mental stress have been linked to incident hypertension and subclinical cardiac remodelling, even in normotensive individuals. This review interprets stress-related blood pressure surges and labile hypertension as a neurocardiovascular phenotype along the continuum from normotension to established hypertension. Current evidence on pathophysiology, cardiovascular implications, diagnosis, and therapeutic strategies is summarised, highlighting the need for phenotype-based assessment and prospective studies to define long-term risk and optimal management.Keywords
All Related Versions
This publication has 64 references indexed in Scilit:
- The Overlooked Driver of Hypertension: Mental Stress at the Crossroad of Cardiology and PsychiatryCurrent Atherosclerosis Reports, 2025
- Controversies in Hypertension VI: Paroxysmal HypertensionThe American Journal of Medicine, 2025
- Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countrieseClinicalMedicine, 2023
- Neurogenic Background for Emotional Stress-Associated HypertensionCurrent Hypertension Reports, 2023
- Treatment of HypertensionJAMA, 2022
- Clarifying the Cause and Treatment of Paroxysmal Hypertension (Pseudopheochromocytoma)Current Hypertension Reports, 2022
- Estimated Prevalence of Masked Asleep Hypertension in US AdultsJAMA Cardiology, 2021
- Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later LifeJAMA Cardiology, 2020
- Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical OutcomesJAMA Cardiology, 2019
- Anxiety in the “Age of Hypertension”Current Hypertension Reports, 2014